R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Sales & Marketing
12 Questions with Dr James Burt
Sponsored

12 Questions with Dr James Burt

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

Sales & Marketing

Sales & Marketing
12 Questions with Dr James Burt
Sponsored

12 Questions with Dr James Burt

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
ASCO 2024 - Steve Devine interview with Jonah Comstock

ASCO 2024 - Steve Devine

While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.

Oncology
ASCO 2024 - Chris Haqq interview with Jonah Comstock

ASCO 2024 - Chris Haqq

ASCO isn’t just a show for top 10 pharmas and Phase 3 readouts; it’s also a conference where smaller biopharmas share encouraging early-stage results, especially those that point to a new p

Patients

R&D

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr